CI Private Wealth »

Biosante Pharmaceuticals shares owned by CI Private Wealth

Quarter-by-quarter ownership of Biosante Pharmaceuticals (ANIP) shares owned by CI Private Wealth from 13F filings

Historical chart of CI Private Wealth investment in Biosante Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Biosante Pharmaceuticals held by CI Private Wealth consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biosante Pharmaceuticals by CI Private Wealth

Quarter filed Position value Share count Share price at filing
2026-03-31 $939k 12k 75.99

More positions owned by CI Private Wealth

Ishares Tr Core S&p500 Etf (IVV)
Apple (AAPL)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Alphabet Cap Stk Cl C (GOOG)
Broadcom (AVGO)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
JPMorgan Chase & Co. (JPM)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Costco Wholesale Corporation (COST)
Johnson & Johnson (JNJ)

View all positions for CI Private Wealth

Top funds holding Biosante Pharmaceuticals

BlackRock
Vanguard Group
Vanguard Capital Management
Soleus Capital Management
State Street Corporation
Tang Capital Management
Deep Track Capital
Millennium Management
Dimensional Fund Advisors
UBS Group
Geode Capital Management
Arrowstreet Capital, Limited Partnership
Nuveen
Vanguard Portfolio Management
Ranger Investment Management

View all funds holding Biosante Pharmaceuticals